Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.
Schäkel K, Reich K, Asadullah K, Pinter A, Jullien D, Weisenseel P, Paul C, Gomez M, Wegner S, Personke Y, Kreimendahl F, Chen Y, Angsana J, Leung MWL, Eyerich K. Schäkel K, et al. Among authors: gomez m. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):2016-2027. doi: 10.1111/jdv.19236. Epub 2023 Jul 18. J Eur Acad Dermatol Venereol. 2023. PMID: 37262309 Clinical Trial.
Real-world effectiveness of guselkumab in patients with psoriasis: Health-related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERSIST trial.
Gerdes S, Bräu B, Hoffmann M, Korge B, Mortazawi D, Wiemers F, Wegner S, Personke Y, Gomez M, Sticherling M. Gerdes S, et al. Among authors: gomez m. J Dermatol. 2021 Dec;48(12):1854-1862. doi: 10.1111/1346-8138.16128. Epub 2021 Sep 12. J Dermatol. 2021. PMID: 34510527
Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.
Gerdes S, Asadullah K, Hoffmann M, Korge B, Mortazawi D, Wegner S, Personke Y, Gomez M, Sticherling M. Gerdes S, et al. Among authors: gomez m. J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1568-1577. doi: 10.1111/jdv.18218. Epub 2022 May 25. J Eur Acad Dermatol Venereol. 2022. PMID: 35569014
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.
Gerdes S, Hoffmann M, Asadullah K, Korge B, Mortazawi D, Krüger N, Personke Y, Tabori S, Gomez M, Wegner S, Kreimendahl F, Taut F, Sticherling M. Gerdes S, et al. Among authors: gomez m. J Eur Acad Dermatol Venereol. 2023 Jul 18. doi: 10.1111/jdv.19296. Online ahead of print. J Eur Acad Dermatol Venereol. 2023. PMID: 37462295
Adherence to the Mediterranean Diet and its association with sustainable dietary behaviors, sociodemographic factors, and lifestyle: a cross-sectional study in US University students.
Franchini C, Biasini B, Sogari G, Wongprawmas R, Andreani G, Dolgopolova I, Gómez MI, Roosen J, Menozzi D, Mora C, Scazzina F, Rosi A. Franchini C, et al. Among authors: gomez mi. Nutr J. 2024 May 27;23(1):56. doi: 10.1186/s12937-024-00962-0. Nutr J. 2024. PMID: 38797846 Free PMC article.
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Baumbach A, van Royen N, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, Unic D, Merkely B, Hermanides RS, Ninios V, Protasiewicz M, Rensing BJWM, Martin PL, Feres F, De Sousa Almeida M, van Belle E, Linke A, Ielasi A, Montorfano M, Webster M, Toutouzas K, Teiger E, Bedogni F, Voskuil M, Pan M, Angerås O, Kim WK, Rothe J, Kristić I, Peral V, Garg S, Elzomor H, Tobe A, Morice MC, Onuma Y, Soliman O, Serruys PW; LANDMARK trial investigators. Baumbach A, et al. Lancet. 2024 May 22:S0140-6736(24)00821-3. doi: 10.1016/S0140-6736(24)00821-3. Online ahead of print. Lancet. 2024. PMID: 38795719
A pro-reparative bioelectronic device for controlled delivery of ions and biomolecules.
Asefifeyzabadi N, Nguyen T, Li H, Zhu K, Yang HY, Baniya P, Medina Lopez A, Gallegos A, Hsieh HC, Dechiraju H, Hernandez C, Schorger K, Recendez C, Tebyani M, Selberg J, Luo L, Muzzy E, Hsieh C, Barbee A, Orozco J, Alhamo MA, Levin M, Aslankoohi E, Gomez M, Zhao M, Teodorescu M, Isseroff RR, Rolandi M. Asefifeyzabadi N, et al. Among authors: gomez m. Wound Repair Regen. 2024 May 25. doi: 10.1111/wrr.13191. Online ahead of print. Wound Repair Regen. 2024. PMID: 38794912
Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control: Novel Therapeutic Target.
Díaz-Guerra A, Villena-Gutiérrez R, Clemente-Moragón A, Gómez M, Oliver E, Fernández-Tocino M, Galán-Arriola C, Cádiz L, Ibáñez B. Díaz-Guerra A, et al. Among authors: gomez m. JACC CardioOncol. 2024 Apr 16;6(2):217-232. doi: 10.1016/j.jaccao.2024.02.005. eCollection 2024 Apr. JACC CardioOncol. 2024. PMID: 38774018 Free PMC article.
4,282 results